Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pirfenidone industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Incepta Pharmaceuticals
Koye Pharmaceuticals
Beijing Continent
Cipla
Zydus Cadila
Wockhardt
Lupin Ltd
GNI Group
Genentech (Roche)
Shionogi
Glenmark Pharmaceuticals
By Type:
Tablet
Capsule
By Application:
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pirfenidone Market Overview 2018-2029
-
1.1 China Pirfenidone Industry Development Overview
-
1.2 China Pirfenidone Industry Development History
-
1.3 China Pirfenidone Industry Market Size (2018-2029)
-
1.4 China Pirfenidone Market Analysis by Type from Production Side
-
1.4.1 China Pirfenidone Production Volume, Production Value and Growth Rate of Tablet (2018-2029)
-
1.4.2 China Pirfenidone Production Volume, Production Value and Growth Rate of Capsule (2018-2029)
-
1.5 China Pirfenidone Market Analysis by Application from Consumption End
-
1.5.1 China Pirfenidone Sales Volume, Sales Value and Growth Rate of Mild Idiopathic Pulmonary Fibrosis (2018-2029)
-
1.5.2 China Pirfenidone Sales Volume, Sales Value and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis (2018-2029)
-
1.6 China Pirfenidone Market Analysis by Region
-
1.6.1 North China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pirfenidone Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pirfenidone Market Size and Growth Rate from 2018-2029
Chapter 2 China Pirfenidone Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pirfenidone Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pirfenidone Market Status and Competition Analysis in 2023
-
2.2.3 China Pirfenidone Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pirfenidone Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pirfenidone Industry Development
Chapter 3 PirfenidoneIndustry Chain Analysis
-
3.1 Pirfenidone Industry Chain
-
3.2 Pirfenidone Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pirfenidone Market
-
3.3 Pirfenidone Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pirfenidone Market
Chapter 4 China Pirfenidone Market, by Type
-
4.1 China Pirfenidone Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pirfenidone Total Production Volume and Growth Rate from Production Side
-
4.5 China Pirfenidone Production Volume and Growth Rate, by Type
-
4.5.1 China Pirfenidone Production Volume and Growth Rate of Tablet
-
4.5.2 China Pirfenidone Production Volume and Growth Rate of Capsule
Chapter 5 China Pirfenidone Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pirfenidone Total Market Size and Growth Rate from Consumption End
-
5.5 China Pirfenidone Market Size and Growth Rate, by Application
-
5.5.1 China Pirfenidone Market Size and Growth Rate of Mild Idiopathic Pulmonary Fibrosis
-
5.5.2 China Pirfenidone Market Size and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis
Chapter 6 China Pirfenidone Market, by Region
-
6.1 China Pirfenidone Production Volume and Production Value, by Region
-
6.2 China Pirfenidone Sales Volume and Sales Value, by Region
Chapter 7 North China Pirfenidone Market Analysis
-
7.1 North China Pirfenidone Market, by Type
-
7.2 North China Pirfenidone Market, by Application
Chapter 8 Central China Pirfenidone Market Analysis
-
8.1 Central China Pirfenidone Market, by Type
-
8.2 Central China Pirfenidone Market, by Application
Chapter 9 South China Pirfenidone Market Analysis
-
9.1 South China Pirfenidone Market, by Type
-
9.2 South China Pirfenidone Market, by Application
Chapter 10 East China Pirfenidone Market Analysis
-
10.1 East China Pirfenidone Market, by Type
-
10.2 East China Pirfenidone Market, by Application
Chapter 11 Northeast China Pirfenidone Market Analysis
-
11.1 Northeast China Pirfenidone Market, by Type
-
11.2 Northeast China Pirfenidone Market, by Application
Chapter 12 Southwest China Pirfenidone Market Analysis
-
12.1 Southwest China Pirfenidone Market, by Type
-
12.2 Southwest China Pirfenidone Market, by Application
Chapter 13 Northwest China Pirfenidone Market Analysis
-
13.1 Northwest China Pirfenidone Market, by Type
-
13.2 Northwest China Pirfenidone Market, by Application
Chapter 14 Company Profiles
-
14.1 Incepta Pharmaceuticals
-
14.1.1 Incepta Pharmaceuticals Company Profile
-
14.1.2 Incepta Pharmaceuticals Pirfenidone Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Koye Pharmaceuticals
-
14.2.1 Koye Pharmaceuticals Company Profile
-
14.2.2 Koye Pharmaceuticals Pirfenidone Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Beijing Continent
-
14.3.1 Beijing Continent Company Profile
-
14.3.2 Beijing Continent Pirfenidone Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Cipla
-
14.4.1 Cipla Company Profile
-
14.4.2 Cipla Pirfenidone Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Zydus Cadila
-
14.5.1 Zydus Cadila Company Profile
-
14.5.2 Zydus Cadila Pirfenidone Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Wockhardt
-
14.6.1 Wockhardt Company Profile
-
14.6.2 Wockhardt Pirfenidone Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Lupin Ltd
-
14.7.1 Lupin Ltd Company Profile
-
14.7.2 Lupin Ltd Pirfenidone Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 GNI Group
-
14.8.1 GNI Group Company Profile
-
14.8.2 GNI Group Pirfenidone Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Genentech (Roche)
-
14.9.1 Genentech (Roche) Company Profile
-
14.9.2 Genentech (Roche) Pirfenidone Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Shionogi
-
14.10.1 Shionogi Company Profile
-
14.10.2 Shionogi Pirfenidone Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Glenmark Pharmaceuticals
-
14.11.1 Glenmark Pharmaceuticals Company Profile
-
14.11.2 Glenmark Pharmaceuticals Pirfenidone Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pirfenidone Industry Research Conclusions
-
15.2 Pirfenidone Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pirfenidone Industry Market Size (2018-2029)
-
Figure China Pirfenidone Production Volume, Production Value and Growth Rate of Tablet (2018-2029)
-
Figure China Pirfenidone Production Volume, Production Value and Growth Rate of Capsule (2018-2029)
-
Figure China Pirfenidone Sales Volume, Sales Value and Growth Rate of Mild Idiopathic Pulmonary Fibrosis (2018-2029)
-
Figure China Pirfenidone Sales Volume, Sales Value and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis (2018-2029)
-
Figure North China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure Central China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure South China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure East China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pirfenidone Market Size and Growth Rate from 2018-2029
-
Figure Pirfenidone Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pirfenidone Market Share by Type in 2018
-
Figure China Pirfenidone Market Share by Type in 2023
-
Figure China Pirfenidone Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pirfenidone Production Volume and Growth Rate of Tablet (2018-2023)
-
Figure China Pirfenidone Production Volume and Growth Rate of Capsule (2018-2023)
-
Figure China Pirfenidone Market Share by Application in 2018
-
Figure China Pirfenidone Market Share by Application in 2023
-
Figure China Pirfenidone Total Market Size and Growth Rate from Consumption End
-
Figure China Pirfenidone Market Size and Growth Rate of Mild Idiopathic Pulmonary Fibrosis (2018-2023)
-
Figure China Pirfenidone Market Size and Growth Rate of Moderate Idiopathic Pulmonary Fibrosis (2018-2023)
-
Table China Pirfenidone Production Volume by Region (2018-2023)
-
Table China Pirfenidone Production Volume Share by Region (2018-2023)
-
Figure China Pirfenidone Production Volume Share by Region (2018-2023)
-
Table China Pirfenidone Production Value by Region (2018-2023)
-
Table China Pirfenidone Production Value Share by Region (2018-2023)
-
Figure China Pirfenidone Production Value Share by Region (2018-2023)
-
Table China Pirfenidone Sales Volume by Region (2018-2023)
-
Table China Pirfenidone Sales Volume Share by Region (2018-2023)
-
Figure China Pirfenidone Sales Volume Share by Region (2018-2023)
-
Table China Pirfenidone Sales Value by Region (2018-2023)
-
Table China Pirfenidone Sales Value Share by Region (2018-2023)
-
Figure China Pirfenidone Sales Value Share by Region (2018-2023)
-
Table North China Pirfenidone Production Volume by Type (2018-2023)
-
Table North China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure North China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table North China Pirfenidone Sales Volume by Application (2018-2023)
-
Table North China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure North China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table Central China Pirfenidone Production Volume by Type (2018-2023)
-
Table Central China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure Central China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table Central China Pirfenidone Sales Volume by Application (2018-2023)
-
Table Central China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure Central China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table South China Pirfenidone Production Volume by Type (2018-2023)
-
Table South China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure South China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table South China Pirfenidone Sales Volume by Application (2018-2023)
-
Table South China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure South China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table East China Pirfenidone Production Volume by Type (2018-2023)
-
Table East China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure East China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table East China Pirfenidone Sales Volume by Application (2018-2023)
-
Table East China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure East China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pirfenidone Production Volume by Type (2018-2023)
-
Table Northeast China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table Northeast China Pirfenidone Sales Volume by Application (2018-2023)
-
Table Northeast China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pirfenidone Production Volume by Type (2018-2023)
-
Table Southwest China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table Southwest China Pirfenidone Sales Volume by Application (2018-2023)
-
Table Southwest China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pirfenidone Production Volume by Type (2018-2023)
-
Table Northwest China Pirfenidone Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pirfenidone Production Volume Share by Type (2018-2023)
-
Table Northwest China Pirfenidone Sales Volume by Application (2018-2023)
-
Table Northwest China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pirfenidone Sales Volume Share by Application (2018-2023)
-
Table Incepta Pharmaceuticals Company Profile
-
Table Incepta Pharmaceuticals Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Koye Pharmaceuticals Company Profile
-
Table Koye Pharmaceuticals Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Beijing Continent Company Profile
-
Table Beijing Continent Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Cipla Company Profile
-
Table Cipla Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Zydus Cadila Company Profile
-
Table Zydus Cadila Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Wockhardt Company Profile
-
Table Wockhardt Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Lupin Ltd Company Profile
-
Table Lupin Ltd Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table GNI Group Company Profile
-
Table GNI Group Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Genentech (Roche) Company Profile
-
Table Genentech (Roche) Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Shionogi Company Profile
-
Table Shionogi Pirfenidone Revenue, Price and Gross (2018-2023)
-
Table Glenmark Pharmaceuticals Company Profile
-
Table Glenmark Pharmaceuticals Pirfenidone Revenue, Price and Gross (2018-2023)
-
